MedTrace Logo

The Natural History of Metachromatic Leukodystrophy

NCT00639132 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-05-30

No results posted yet for this study

Summary

There have not been longitudinal studies which track patients' neurologically or developmentally in a systematic manner. By simultaneously tracking patients' neurodevelopment along with neuroimaging and neurophysiologic studies it becomes much easier to draw conclusions on the differential effects of the disease process and any available treatments that patients might receive. In addition, many of the gene mutations, which cause MLD have not been linked to the age of onset or the expected disease course.

Conditions

  • Metachromatic Leukodystrophy

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Eligibility

Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-11
Primary Completion
2022-01-30
Completion
2022-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639132 on ClinicalTrials.gov